Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) Xylocaine 2% with Epinephrine - lidocaine hydrochloride and epinephrine injection USP 20mL vial (Aspen)
Section 19A approved medicine
(Approval lapsed) Xylocaine 2% with Epinephrine - lidocaine hydrochloride and epinephrine injection USP 20mL vial (Aspen)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
Xylocaine 2.0% with adrenaline (epinephrine) 1:200,000 20mL injection vial - ARTG -12021
Indication(s)
XYLOCAINE solutions are indicated for the production of local or regional anaesthesia by the following techniques:
- infiltration,
- intravenous regional anaesthesia - excluding solutions with adrenaline (epinephrine) acid tartrate,
- peripheral nerve block such as intercostal block,
- major plexus block such as brachial plexus block,
- epidural block,
- subarachnoid block.